Drug–Drug Interactions of a Novel κ-Opioid Receptor Agonist, Nalfurafine Hydrochloride, Involving the P-Glycoprotein
Authors:
- 10 June 2015
- journal article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 41 (5) , 549-558
Abstract
Nalfurafine hydrochloride (TRK-820), which exhibits strong κ-opioid agonistic activity, has an antipruritic effect on uremic pruritus. The permeability of nalfurafine across human P-glycoprotein (P-gp)-expressing LLC-PK1 cells was investigated to evaluate drug–drug interactions (DDI) involving the P-gp efflux transporter of nalfurafine. Furthermore, we assessed the ratio of brain/plasma concentrations (K p) as an indicator to investigate the changes in the blood–brain barrier (BBB) transport through P-gp when digoxin or verapamil was concomitantly administered with nalfurafine in mice. All samples were analyzed by liquid chromatography–tandem mass spectrometry or a liquid scintillation counter. The cleared volume ratio (cleared volume from basal to apical/cleared volume from apical to basal) of nalfurafine in P-gp-expressing cells was higher than that in the control cells; however, no concentration-dependent decrease in the cleared volume ratio of digoxin was observed in the presence of nalfurafine. The K p value in mice showed similar profiles to those observed with nalfurafine alone and when co-administered with digoxin or verapamil. From these results, nalfurafine was found to be a substrate for P-gp, but had no inhibitory effect on P-gp-mediated transport. Furthermore, it is unlikely that nalfurafine transport via the BBB is affected by P-gp substrates in humans.Keywords
This publication has 23 references indexed in Scilit:
- Systemic Kappa Opioid Receptor Agonists in the Treatment of Chronic Pruritus: A Literature ReviewActa Dermato-Venereologica, 2012
- Drug interactions at the blood-brain barrier: Fact or fantasy?☆Pharmacology & Therapeutics, 2009
- Nalfurafine hydrochloride: A new drug for the treatment of uremic pruritus in hemodialysis patientsDrugs of Today, 2009
- κ-Opioid System in Uremic PruritusJournal of the American Society of Nephrology, 2005
- Interactions between P‐glycoprotein substrates and other cationic drugs at the hepatic excretory levelBritish Journal of Pharmacology, 1998
- Human μ opiate receptorFEBS Letters, 1994
- Identification of a human delta opioid receptor: Cloning and expressionLife Sciences, 1994
- κ-Opioid receptors and analgesiaTrends in Pharmacological Sciences, 1990
- Role of Opioid Receptors in Bombesin‐induced GroomingaAnnals of the New York Academy of Sciences, 1988
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976